In this retrospective multicenter study , 473 patients with HCV-4 were selected from databases at 7 Belgian centers ; 209 treatment-naive patients ( 154 BA ) had received treatment with peg-interferon ( peg-IFN ) plus ribavirin ( RBV ) and were included in the study .